SCHEMBL9342013

SCHEMBL9342013

Cc1coc(C2CN3CCC2CC3)n1

nearest known ligand 0.56

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 2/20 0.48
CHRM4 P08173 1/20 0.44
CHRM5 P08912 1/20 0.44
CHRM1 P11229 1/20 0.44
CHRM3 P20309 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9342153 0.98 CHRM2 (0.47) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL9341869 0.80 CHRM2 (0.41) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL9346285 0.74 CHRM2 (0.44) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL661864 0.72 CHRM2 (0.85) CHRM2CHRM1
Fumaric Acid SCHEMBL9346296 0.71 CHRNA7 (0.41) CHRM2
SCHEMBL9346211 0.71 CHRM2 (0.44) CHRM2
SCHEMBL8935450 0.71 CHRNB2 (0.49) CHRM2CHRM4CHRM5CHRM1CHRM3
Hydrochloric Acid SCHEMBL8871854 0.71 CHRM2 (0.82) CHRM2CHRM1
SCHEMBL9373682 0.70 CHRM2 (0.50) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL9369083 0.70 CHRM2 (0.46) CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0307141-B1 OXAZOLES AND THIAZOLES FOR THE TREATMENT OF SENILE DEMENTIA MERCK SHARP & DOHME LTD. (GB) 1993-01-13 EP claimed
EP-0307141-A2 Oxazoles and thiazoles for the treatment of senile dementia MERCK SHARP & DOHME LTD. (GB) 1989-03-15 EP claimed
US-5324723-A Analgesics MERCK SHARPE & DOHME LTD. 1994-06-28 US disclosed
EP-0307141-B1 OXAZOLES AND THIAZOLES FOR THE TREATMENT OF SENILE DEMENTIA MERCK SHARP & DOHME LTD. (GB) 1993-01-13 EP disclosed
EP-0307141-A2 Oxazoles and thiazoles for the treatment of senile dementia MERCK SHARP & DOHME LTD. (GB) 1989-03-15 EP disclosed